CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
37.630
2.7%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.130
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02141 %
Charges from full value of position ($-4.07)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02141%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.000812 %
Charges from full value of position ($-0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000812%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 38.675
Open 37.965
1-Year Change -6.73%
Day's Range 37.575 - 38.06
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 19, 2024 37.630 -0.645 -1.69% 38.275 38.340 37.510
Jul 18, 2024 38.675 -0.085 -0.22% 38.760 39.015 38.520
Jul 17, 2024 38.745 0.440 1.15% 38.305 39.065 38.305
Jul 16, 2024 38.500 0.560 1.48% 37.940 38.525 37.875
Jul 15, 2024 38.020 -0.310 -0.81% 38.330 38.730 38.015
Jul 12, 2024 38.340 0.435 1.15% 37.905 38.720 37.895
Jul 11, 2024 38.100 0.150 0.40% 37.950 38.295 37.590
Jul 10, 2024 37.565 0.420 1.13% 37.145 37.645 36.970
Jul 9, 2024 36.790 -0.260 -0.70% 37.050 37.520 36.685
Jul 8, 2024 37.340 -0.355 -0.94% 37.695 37.920 37.280
Jul 5, 2024 37.780 0.570 1.53% 37.210 37.970 37.210
Jul 4, 2024 37.655 0.460 1.24% 37.195 37.935 37.180
Jul 3, 2024 37.525 -0.220 -0.58% 37.745 38.055 37.270
Jul 2, 2024 37.775 0.280 0.75% 37.495 37.795 37.205
Jul 1, 2024 37.810 -0.775 -2.01% 38.585 38.635 37.785
Jun 28, 2024 38.560 0.150 0.39% 38.410 38.800 38.125
Jun 27, 2024 38.195 0.185 0.49% 38.010 38.685 37.830
Jun 26, 2024 38.175 -0.270 -0.70% 38.445 38.780 38.005
Jun 25, 2024 38.660 -0.405 -1.04% 39.065 39.135 38.530
Jun 24, 2024 39.140 0.200 0.51% 38.940 39.200 38.490

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

People also watch

ETH/USD

3,519.78 Price
-0.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.61 Price
+1.000% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

19,526.60 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

68,249.25 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading